Literature DB >> 15974297

Fine mapping and SNP analysis of positional candidates at the preeclampsia susceptibility locus (PREG1) on chromosome 2.

E Fitzpatrick1, H H H Göring, H Liu, A Borg, S Forrest, D W Cooper, S P Brennecke, E K Moses.   

Abstract

Genome scans in Icelandic, Australian and New Zealand, and Finnish families have localized putative susceptibility loci for preeclampsia/ eclampsia to chromosome 2. The locus mapped in the Australian and New Zealand study (designated PREG1) was thought to be the same locus as that identified in the Icelandic study. In both these studies, two distinct quantitative trait locus (QTL) regions were evident on chromosome 2. Here, we describe our fine mapping of the PREG1 locus and a genetic analysis of two positional candidate genes. Twenty-five additional microsatellite markers were genotyped within the 74-cM linkage region defined by the combined Icelandic and Australian and New Zealand genome scans. The overall position and shape of the localization evidence obtained using nonparametric multipoint analysis did not change from that seen previously in our 10-cM resolution genome scan; two peaks were displayed, one on chromosome 2p at marker D2S388 (107.46 cM) and the other on chromosome 2q at 151.5 cM at marker D2S2313. Using the robust two-point linkage analysis implemented in the Analyze program, all 25 markers gave positive LOD scores with significant evidence of linkage being seen at marker D2S2313 (151.5 cM), achieving a LOD score of 3.37 under a strict diagnostic model. Suggestive evidence of linkage was seen at marker D2S388 (107.46 cM) with a LOD score of 2.22 under the general diagnostic model. Two candidate genes beneath the peak on chromosome 2p were selected for further analysis using public single nucleotide polymorphisms (SNPs) within these genes. Maximum LOD scores were obtained for an SNP in TACR1 (LOD = 3.5) and for an SNP in TCF7L1 (LOD = 3.33), both achieving genome-wide significance. However, no evidence of association was seen with any of the markers tested. These data strongly support the presence of a susceptibility gene on chromosome 2p11-12 and substantiate the possibility of a second locus on chromosome 2q23.

Entities:  

Mesh:

Year:  2004        PMID: 15974297     DOI: 10.1353/hub.2005.0017

Source DB:  PubMed          Journal:  Hum Biol        ISSN: 0018-7143            Impact factor:   0.553


  10 in total

1.  Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia.

Authors:  Ossama M Reslan; Raouf A Khalil
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2010-10-01

Review 2.  Genetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy.

Authors:  Sajjadh M J Ali; Raouf A Khalil
Journal:  Expert Opin Ther Targets       Date:  2015-08-17       Impact factor: 6.902

3.  Heterogeneity-based genome search meta-analysis for preeclampsia.

Authors:  Elias Zintzaras; Georgios Kitsios; Gavan A Harrison; Hannele Laivuori; Katja Kivinen; Juha Kere; Ioannis Messinis; Ioannis Stefanidis; John P A Ioannidis
Journal:  Hum Genet       Date:  2006-07-26       Impact factor: 4.132

4.  The ERAP2 gene is associated with preeclampsia in Australian and Norwegian populations.

Authors:  Matthew P Johnson; Linda T Roten; Thomas D Dyer; Christine E East; Siri Forsmo; John Blangero; Shaun P Brennecke; Rigmor Austgulen; Eric K Moses
Journal:  Hum Genet       Date:  2009-07-04       Impact factor: 4.132

5.  Genetic association of the activin A receptor gene (ACVR2A) and pre-eclampsia.

Authors:  E Fitzpatrick; M P Johnson; T D Dyer; S Forrest; K Elliott; J Blangero; S P Brennecke; E K Moses
Journal:  Mol Hum Reprod       Date:  2009-01-06       Impact factor: 4.025

Review 6.  Risk factors and mediators of the vascular dysfunction associated with hypertension in pregnancy.

Authors:  Stephanie J Sheppard; Raouf A Khalil
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2010-03

Review 7.  (Epi)genetics of pregnancy-associated diseases.

Authors:  Marie van Dijk; Cees Oudejans
Journal:  Front Genet       Date:  2013-09-10       Impact factor: 4.599

Review 8.  STOX1: Key player in trophoblast dysfunction underlying early onset preeclampsia with growth retardation.

Authors:  Marie van Dijk; Cees B M Oudejans
Journal:  J Pregnancy       Date:  2010-12-15

9.  Genetic and molecular functional characterization of variants within TNFSF13B, a positional candidate preeclampsia susceptibility gene on 13q.

Authors:  Mona H Fenstad; Matthew P Johnson; Linda T Roten; Per A Aas; Siri Forsmo; Kjetil Klepper; Christine E East; Lawrence J Abraham; John Blangero; Shaun P Brennecke; Rigmor Austgulen; Eric K Moses
Journal:  PLoS One       Date:  2010-09-29       Impact factor: 3.240

10.  Genome-wide association scan identifies a risk locus for preeclampsia on 2q14, near the inhibin, beta B gene.

Authors:  Matthew P Johnson; Shaun P Brennecke; Christine E East; Harald H H Göring; Jack W Kent; Thomas D Dyer; Joanne M Said; Linda T Roten; Ann-Charlotte Iversen; Lawrence J Abraham; Seppo Heinonen; Eero Kajantie; Juha Kere; Katja Kivinen; Anneli Pouta; Hannele Laivuori; Rigmor Austgulen; John Blangero; Eric K Moses
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.